PHARMACEUTICAL
Colombia is an ideal destination for investment in pharmaceuticals, thanks to its history as a producer and exporter, its geographic position that makes it an ideal center for production and distribution, its large market with high consumption levels, and its ecosystem of state agencies, guilds, and associations.
Multinational companies consider Colombia a center for the production and distribution of pharmaceutical products to the region. Its developed healthcare system, domestic consumption and ecosystem of agencies and associations that support the sector in Colombia make the country an ideal investment destination.
Pharmaceutical product sales in Colombia by segment, 2025
Source: BMI, Fitch Solutions
COLOMBIA'S HEALTHCARE SYSTEM IS WELL DEVELOPED AND OFFERS HIGH-QUALITY SERVICES
-
The country has a population of over 52 million people with universal health coverage. In 2024, 23.3 million people belonged to the contributory regime and 27 million to the subsidized one, reaching nearly 98% of the population covered by the health system.
-
Colombia ranks fourth among countries in the region in terms of public health expenditure as a share of total health spending.
-
Nearly half of the top hospitals in Latin America are located in Colombia (LatAm Business Conference – LBC).
-
In Colombia, there are 9 institutions with Joint Commission International certification, some of which have maintained this standard of excellence for over 15 years.
DEMAND FOR PHARMACEUTICAL PRODUCTS IN COLOMBIA IS HIGH AND GROWING
-
Investment in infrastructure, advances in telemedicine, and a stronger focus on preventive medicine are driving pharmaceutical demand. In 2025, pharmaceutical product sales were estimated at USD 5,978 million, positioning Colombia as the third-largest market in Latin America.
-
Generic pharmaceuticals accounted for the largest share of sales at 51%, and sales of both generic and patented products are expected to increase in the next years.
-
Most leading multinational companies specializing in OTC products have a presence in Colombia.
-
On average, Colombian imports of pharmaceuticals for human use have grown by nearly 14% annually over the past decade. In 2024, these imports reached USD 3,826 million, with the United States (16.4%) and Germany (14.6%) establishing themselves as the leading suppliers, together accounting for nearly one-third of the total imported.
COLOMBIA IS A COMPETITIVE EXPORT PLATFORM FOR PHARMACEUTICALS IN THE REGION
-
On average, Colombian exports of pharmaceuticals for human use have grown by nearly 2% annually over the past decade. In 2024, exports reached USD 340 million, with more than 90% destined for Latin American countries.
-
Several companies have selected Colombia as an export hub in the region, leveraging its network of trade agreements. In 2024, 136 companies reported exports exceeding USD 10,000.
-
The country's privileged geographic location and excellent air connectivity provide significant added value.
-
INVIMA, Colombia's health regulatory agency, has been internationally recognized for its high regulatory standards and classified as a Level 4 authority by PAHO/WHO.
THE COUNTRY STANDS OUT FOR ITS STABILITY AND BUSINESS-FRIENDLY ENVIRONMENT
-
Colombia is a full member of the Organisation for Economic Co-operation and Development (OECD), strengthening its image in terms of political and economic stability.
-
The environment for foreign direct investment is business-friendly, characterized by dynamic and diversified investment in recent years.
-
Colombia's exchange rate represents an advantage for international investors.
THE COLOMBIAN PHARMACEUTICAL SECTOR OFFERS MULTIPLE BUSINESS OPPORTUNITIES
-
Acquisition of local laboratories and/or product lines.
-
Attract contract research organizations (CROs) specialized in clinical studies for medical devices.
-
Development of logistics and production centers to supply the growing Latin American market.
-
Establishment of clinical research centers with new technologies that enable the conduct of clinical studies for different therapeutic areas.
-
Establishment of production centers for sophisticated generic medicines.
-
Establishment of production centers for sophisticated, biotechnological and biosimilar medicines.
-
Establishment of companies dedicated to the manufacturing, filling and packaging of vaccines.
We are part of your team
PROCOLOMBIA is the entity in charge of promoting Exports, International Tourism, Foreign Direct Investment and the Country Brand, in order to position Colombia in the world. Get to know the national and international network of offices, where you will find comprehensive support and advice.